Press release
The Oncolytic Virus Immunotherapy Market to look through AI-based genomics at a CAGR of 12%
Oncolytic virus immunotherapy is an emerging field of cancer treatment that involves using viruses to target and destroy cancer cells while leaving healthy cells intact. This type of therapy is gaining popularity in the cancer treatment space due to its potential to effectively treat a wide range of cancer types with fewer side effects than traditional chemotherapy and radiation therapy. The global oncolytic virus immunotherapy market is expected to grow significantly in the coming years.
Market Overview:
A new study by Persistence Market Research predicts that the global oncolytic virus immunotherapy market will be valued at ~ US$ 214 Mn by 2029-end, expanding at a promising CAGR of ~12% during the forecast period of 2019-2029. Over the past five years, more than 70 new cancer treatments have been launched and are utilized for treatment in over 20 different types of tumor. Moreover, new treatment options are available since the past five years, and the surge in innovation is anticipated to increase the number of candidates in clinical stage development by an outsized and varied group of biopharmaceutical companies. Further, the pipeline of cancer drugs in early clinical development has increased by more than 60% over the past decade, with almost 90% of the focus on targeted agents.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/15262
Company Profiles:
BioVex, Inc. (Amgen, Inc.)
Cold Genesys, Inc.
DNAtrix Therapeutics
Genelux Corporation
Lokon Pharma AB
Oncolytics Biotech, Inc.
ORYX GmbH & Co. KG
PsiOxus Therapeutics
SillaJen, Inc.
Sorrento Therapeutics, Inc.
Takara Bio
Targovax ASA
Transgene sa
Turnstone Biologics
VCN Biosciences
Viralytics Ltd. (Merck & Co., Inc.)
Vyriad
Shanghai Sunway Biotech
Drivers and Restraints:
One of the major drivers for the growth of the oncolytic virus immunotherapy market is the increasing prevalence of cancer worldwide. Additionally, increasing investments in research and development of oncolytic viruses and the potential for combination therapy with other immunotherapies is also driving the growth of this market.
The high cost associated with the treatment and the need for specialized infrastructure for their administration is a major restraint for the growth of the oncolytic virus immunotherapy market. Additionally, concerns about the potential for the development of resistance to oncolytic viruses may limit their long-term efficacy.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/15262
Key Segments of the Oncolytic Virus Immunotherapy Market
Indication
Melanoma
Bladder Cancer*
Prostate Cancer*
Colorectal Cancer*
Ovarian Cancer*
Lung Cancer*
Breast Cancer*
Myeloma*
Others*
End User
Hospitals
Specialty Clinics
Cancer Research Institutes
Region
North America
Europe
If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight @ https://www.persistencemarketresearch.com/checkout/15262
Related Reports:
Immuno-Oncology Market
https://www.persistencemarketresearch.com/market-research/immunooncology-market.asp
Ophthalmic Packaging Market
https://www.persistencemarketresearch.com/market-research/ophthalmic-packaging-market.asp
Opioids Market
https://www.persistencemarketresearch.com/market-research/opioids-market.asp
DNA and RNA Sample Preparation Market
https://www.persistencemarketresearch.com/market-research/dna-rna-sample-preparation-market.asp
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Oncolytic Virus Immunotherapy Market to look through AI-based genomics at a CAGR of 12% here
News-ID: 3010608 • Views: …
More Releases from Persistence Market Research
Europe Calf Milk Replacer Market to Reach US$1,657.2 Mn by 2032 | Driven by Risi …
The Europe calf milk replacer market is poised for significant growth over the coming years. The market size is projected to reach US$1,018.6 million in 2025 and is anticipated to expand to US$1,657.2 million by 2032, registering a robust compound annual growth rate (CAGR) of 7.2% during the forecast period from 2025 to 2032. The growth trajectory is driven by the increasing awareness among dairy farmers regarding the nutritional requirements…
Croscarmellose Sodium Market to Reach $487 Mn by 2032, Driven by Rising Pharma D …
The global croscarmellose sodium market is projected to witness significant expansion over the forecast period, reflecting the growing adoption of pharmaceutical excipients across diverse applications. Valued at approximately US$ 288.7 million in 2025, the market is expected to reach US$ 487.0 million by 2032, registering a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032. This growth trajectory is driven primarily by increasing demand for orally disintegrating tablets…
Europe Egg Replacement Ingredients Market to Reach $1,711.1 Mn by 2032, Driven b …
The Europe egg replacement ingredients market is witnessing significant expansion, driven by the increasing adoption of plant-based diets and rising consumer awareness regarding health and wellness. The market size is projected to reach US$ 952.2 million in 2025 and is expected to surge to US$ 1,711.1 million by 2032, registering a robust CAGR of 8.7% over the forecast period from 2025 to 2032. The growing demand for clean-label products, vegan…
Kraft Paper Market to Reach US$ 25.0 Billion by 2032: Growth Driven by Rising De …
The global Kraft Paper market is undergoing significant expansion, driven by the accelerating shift toward eco-friendly packaging materials and the rising global awareness surrounding sustainability. As industries worldwide transition from plastic-based packaging to biodegradable alternatives, kraft paper has emerged as one of the most sought-after materials due to its strength, recyclability, and versatility.
According to the latest study by Persistence Market Research, the global Kraft Paper market size is projected to…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
